Enveric Biosciences

ENVB

Börsenwert 6,45 Mio. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
1	1 Hudson Bay Capital Management Stamford, Connecticut	980.000 $	-48.910 $	-23	-4 %
2	2 AdvisorShares Investments Bethesda, Maryland	268.000 $	+78.681 $	+37	+36 %
3	3 Renaissance Technologies New York	234.000 $	-212.651 $	-100	-45 %
4	4 Vanguard Group Malvern, Pennsylvania	163.000 $	–	–	–
5	5 BlackRock New York	97.000 $	-10.633 $	-5	-9 %
6	6 Millennium Management New York	49.000 $	+53.163 $	+25	Neu
7	7 Ikarian Capital Dallas, Texas	48.000 $	-46.783 $	-22	-47 %
8	8 Geode Capital Management Boston, Massachusetts	43.000 $	+8.506 $	+4	+21 %
9	9 Virtu Financial New York	36.000 $	-25.518 $	-12	-39 %
10	10 State Street Boston, Massachusetts	19.000 $	–	–	–
11	11 Group One Trading Chicago, Illinois	13.000 $	+2.127 $	+1	+17 %
12	12 Tower Research Capital (TRC) New York	9.000 $	+6.380 $	+3	+150 %
13	13 Northern Trust Chicago, Illinois	8.000 $	–	–	–
14	14 Engineers Gate Manager New York	6.000 $	–	–	–
15	15 Scotia Capital Toronto, Ontario, Canada	6.000 $	–	–	–
16	16 Creative Planning Overland Park, Kansas	4.000 $	–	–	–
17	17 Veritable Wilmington, Delaware	4.000 $	+4.253 $	+2	Neu
18	18 Royal Bank of Canada Toronto, Ontario, Canada	2.000 $	+2.127 $	+1	Neu
19	19 Two Sigma Advisers New York	2.000 $	+2.127 $	+1	Neu
20	20 HRT Financial New York	2.000 $	+4.253 $	+2	Neu
21	CG 21 Cutler Group San Francisco, California	1.000 $	–	–	–
22	22 Fidelity Investments Boston, Massachusetts	1 $	–	–	–
23	23 Mirae Asset Global Investments Seoul, South Korea	–	-94.000 $	-32	Geschlossen
24	24 Susquehanna International Group Bala Cynwyd, Pennsylvania	–	-58.000 $	-20	Geschlossen
25	25 T. Rowe Price Associates Baltimore, Maryland	–	-35.000 $	-12	Geschlossen

Enveric Biosciences ENVB Börsenwert 6,45 Mio. $

Enveric Biosciences

ENVB

Börsenwert 6,45 Mio. $